13 research outputs found
Elevated serum interleukin-6 has prognostic significance for postoperative outcome in patients undergoing cardiothoracic surgery
Recommended from our members
Managing the atazanavir–tacrolimus drug interaction in a renal transplant recipient
Elevated serum interleukin-6 has prognostic significance for postoperative outcome in patients undergoing cardiothoracic surgery
Definition and spatial annotation of the dynamic secretome during early kidney development
The term secretome has been defined as a set of secreted proteins (Grimmond et al. [2003] Genome Res 13:1350-1359). The term secreted protein encompasses all proteins exported from the cell including growth factors, extracellular proteinases, morphogens, and extracellular matrix molecules. Defining the genes encoding secreted proteins that change in expression during organogenesis, the dynamic secretome, is likely to point to key drivers of morphogenesis. Such secreted proteins are involved in the reciprocal interactions between the ureteric bud (UB) and the metanephric mesenchyme (AM) that occur during organogenesis of the metanephros. Some key metanephric secreted proteins have been identified, but many remain to be determined. In this study, microarray expression profiling of E10.5, E11.5, and E13.5 kidney and consensus bioinformatic analysis were used to define a dynamic secretome of early metanephric development. In situ hybridisation was used to confirm microarray results and clarify spatial expression patterns for these genes. Forty-one secreted factors were dynamically expressed between the E10.5 and E13.5 timeframe profiled, and 25 of these factors had not previously been implicated in kidney development. A text-based anatomical ontology was used to spatially annotate the expression pattern of these genes in cultured metanephric explants
Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis
Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate
Women with inherited mutations in the BRCA1 gene have increased risk of developing breast cancer but also exhibit a predisposition for the development of aggressive basal-like breast tumors. We report here that breast epithelial cells derived from patients harboring deleterious mutations in BRCA1 (BRCA1[superscript mut/+]) give rise to tumors with increased basal differentiation relative to cells from BRCA1[superscript +/+] patients. Molecular analysis of disease-free breast tissues from BRCA1[superscript mut/+] patients revealed defects in progenitor cell lineage commitment even before cancer incidence. Moreover, we discovered that the transcriptional repressor Slug is an important functional suppressor of human breast progenitor cell lineage commitment and differentiation and that it is aberrantly expressed in BRCA1[superscript mut/+] tissues. Slug expression is necessary for increased basal-like phenotypes prior to and after neoplastic transformation. These findings demonstrate that the genetic background of patient populations, in addition to affecting incidence rates, significantly impacts progenitor cell fate commitment and, therefore, tumor phenotype